Community-Acquired Pneumonia Severity Assessment

Introduction to CURB-65

• The American Thoracic Society recommends using CURB-65 to assess the severity of community-acquired pneumonia, predict mortality risk, and guide site-of-care decisions, including hospital admission and ICU assessment 1, 2

Components and Scoring of CURB-65

• CURB-65 evaluates five clinical parameters: confusion, urea levels, respiratory rate, blood pressure, and age, with one point assigned for each, to predict mortality risk in patients with community-acquired pneumonia 1

Risk Stratification and Clinical Application of CURB-65

• A CURB-65 score of 0-1 is associated with a mortality risk of 0.7-2.1% and recommends consideration of outpatient treatment for patients with community-acquired pneumonia 1, 2
• A CURB-65 score of 2 is associated with a mortality risk of 9.2% and recommends consideration of short hospital stay or supervised outpatient treatment for patients with community-acquired pneumonia 1, 2
• A CURB-65 score of 3 is associated with a mortality risk of 14.5% and recommends hospital admission and assessment for ICU for patients with community-acquired pneumonia 1, 2
• A CURB-65 score of 4-5 is associated with a mortality risk of 40-57% and recommends hospital admission and assessment for ICU for patients with community-acquired pneumonia 1, 2

Advantages of CURB-65

• CURB-65 is a simple and practical tool that uses only five variables, making it more accessible in emergency settings for patients with community-acquired pneumonia 1, 3
• CURB-65 requires only one laboratory test, urea/BUN, which is readily available in most hospitals, to assess the severity of community-acquired pneumonia 1
• CURB-65 helps reduce unnecessary hospitalizations while ensuring appropriate care for higher-risk patients with community-acquired pneumonia 2

Simplified Version: CRB-65

• A variant of CURB-65, CRB-65, omits blood urea nitrogen testing and is available for settings where laboratory tests are not readily accessible for patients with community-acquired pneumonia 2, 3
• CRB-65 is particularly useful in outpatient settings and resource-limited environments for patients with community-acquired pneumonia 2

Limitations and Considerations of CURB-65

• CURB-65 may underestimate severity in young patients with severe respiratory failure and in elderly patients with comorbidities, highlighting the need for clinical judgment in community-acquired pneumonia management 1, 4
• When used for ICU admission decisions, CURB-65 performs less effectively than criteria specifically designed for ICU triage, such as the IDSA/ATS severe CAP criteria, for patients with community-acquired pneumonia 4, 3

Comparison with Other Scoring Systems

• The Pneumonia Severity Index (PSI) is more complex but similarly effective in predicting mortality for patients with community-acquired pneumonia 1, 5
• PSI is primarily designed to identify low-risk patients who can be safely treated as outpatients, whereas CURB-65 is used for a broader range of patients with community-acquired pneumonia 5, 3

Best Practices for Implementation of CURB-65

• Use CURB-65 as an adjunct to clinical judgment, not as the sole determinant for site-of-care decisions, to ensure appropriate management of community-acquired pneumonia 2, 4
• Consider implementing CURB-65 as part of a systematic approach to CAP severity assessment, including prompt evaluation for potential ICU admission for patients with high CURB-65 scores 6
• For patients with CURB-65 scores ≥3, promptly evaluate for potential ICU admission to ensure timely and appropriate care for community-acquired pneumonia 1, 2

Community-Acquired Pneumonia Management

Clinical Decision Tools

• The American Academy of Family Physicians suggests that clinical judgment is particularly important in the intermediate risk group, as indicated by a CURB-65 score of 2, which is associated with a 9.2% mortality risk 7
• The CRB-65, a simplified alternative to CURB-65, omits the urea measurement and can be used when laboratory testing is unavailable, giving a point range from 0 to 4 7
• Consider implementing CURB-65 as part of a systematic pneumonia care bundle, as suggested by the Society of Critical Care Medicine 8

Patient Assessment

• Important comorbidities, such as HIV, should be considered when using the CURB-65 score, as they may affect patient outcomes 7
• Failure of outpatient therapy and social factors affecting medication adherence should also be taken into account when assessing patients with community-acquired pneumonia 7

Community-Acquired Pneumonia Management with CURB-65 Score

Risk Stratification and Treatment Decisions

• Patients with CURB-65 scores ≥2 should be hospitalized or receive intensive in-home health care services, as they face significantly elevated mortality risk and require active intervention for physiologic derangements, with a mortality risk of 9.2% for a score of 2, rising to 40-57% for scores of 4-5 9, 10
• Direct ICU admission is required for patients with septic shock requiring vasopressors or acute respiratory failure requiring intubation and mechanical ventilation, regardless of CURB-65 score 9, 10

ICU Admission Criteria

• Patients meeting ≥3 minor criteria for severe CAP should be admitted directly to ICU or high-level monitoring unit 9, 10
• CURB-65 alone performs poorly for predicting ICU needs; use IDSA/ATS severe CAP criteria instead for ICU triage decisions 11
• The presence of ≥2 of the following warrants ICU consideration: systolic BP <90 mmHg, severe respiratory failure, multilobar involvement, or need for mechanical ventilation/vasopressors 11

Clinical Application and Limitations

• Young patients with severe respiratory failure: CURB-65 may underestimate severity in previously healthy patients under 65 with significant physiologic derangement 10
• Social factors: Consider homelessness, psychiatric illness, inability to take oral medications, and lack of social support—all may necessitate admission despite low scores 10
• Comorbidity exacerbations: Pneumonia may worsen underlying conditions requiring hospitalization independent of CURB-65 10

Monitoring and Follow-up

• Clinical effect should be expected within 3 days; patients should contact their physician if no improvement 12

Comparative Performance

• CURB-65 is preferred for its simplicity and focus on illness severity rather than just mortality risk, according to the Infectious Diseases Society of America (IDSA) 9, 10
• The CRB-65 variant can be used in outpatient settings where laboratory testing is unavailable 12

Community-Acquired Pneumonia Severity Assessment

ICU Admission Criteria

• The Infectious Diseases Society of America (IDSA) and the American Thoracic Society (ATS) recommend direct ICU admission for patients with septic shock requiring vasopressors or acute respiratory failure requiring intubation and mechanical ventilation, regardless of CURB-65 score 13
• For ICU admission decisions, the IDSA/ATS severe CAP criteria should be used instead of CURB-65 alone, as CURB-65 has a sensitivity of only 78.4% for predicting critical care interventions 13

Enhanced Assessment

• The use of pulse oximetry and point-of-care lactate as part of a care bundle approach is recommended for immediate evaluation of pneumonia patients, as postponing oxygenation assessment adversely affects outcomes 13
• The IDSA/ATS recommends admitting patients to the ICU or a high-level monitoring unit if they have ≥3 minor criteria, including respiratory rate ≥30/min, PaO2/FiO2 ratio ≤250, multilobar infiltrates, confusion/disorientation, uremia, leukopenia, thrombocytopenia, hypothermia, or hypotension requiring aggressive fluid resuscitation 13

Specific Patient Populations

• Young patients (<65 years) with severe respiratory failure may have their risk underestimated by CURB-65, as age is heavily weighted in the score 13
• Elderly patients with multiple comorbidities may have falsely elevated CURB-65 scores without true severity 13

Risk Stratification and Management of Community‑Acquired Pneumonia in the Philippines

Primary Risk Stratification Tool – CURB‑65

• The Infectious Diseases Society of America/American Thoracic Society (IDSA/ATS) recommends using CURB‑65 as the initial site‑of‑care decision tool for all adult CAP patients in the Philippines because it is simple, requires only one readily available laboratory test (blood urea nitrogen), and has been validated for mortality prediction. 14
• CURB‑65 assigns one point each for:
• Score 0–1 (low risk): Observed mortality 0.7–2.1 %; outpatient management is appropriate and patients can safely resume work or normal activities sooner than hospitalized patients. 14
• Score ≥ 3 (high/very‑high risk): Hospital admission is required and patients should be evaluated promptly for ICU need. (Guideline‑based recommendation.) 14

Secondary Risk Stratification Tool – Pneumonia Severity Index (PSI)

• The PSI, which incorporates 20 demographic, clinical, laboratory, and radiographic variables, provides a more granular mortality estimate and is recommended when CURB‑65 results are borderline (especially score 2) or when a detailed risk profile is needed. 16
• Class I–II: Mortality ≤ 0.7 %; outpatient treatment is advised. 14
• Class III: Mortality 0.9–2.8 %; observation‑unit care or short hospitalization is appropriate. 14

ICU Admission Criteria – 2007 IDSA/ATS Severe CAP Guidelines

• For ICU triage, the IDSA/ATS severe CAP criteria should be applied because CURB‑65 alone has limited sensitivity for identifying patients who need intensive care. 16
• Major criteria (any one mandates ICU admission):
• Minor criteria (≥ 3 criteria mandate ICU or high‑dependency unit):
• Additional minor criterion: Persistent hypotension despite aggressive fluid resuscitation. 16

Clinical Implementation Algorithm (Guideline‑Based Steps)

Factors That Override a Low CURB‑65 Score (Require Admission)

• Inability to maintain oral intake. 17
• Psychiatric illness impairing medication adherence. 15
• Active substance abuse. 15
• Cognitive impairment affecting self‑care. 14
• Acute exacerbation of comorbidities such as COPD, heart failure, or diabetes. 15
• Prior splenectomy (increased risk of severe infection). 16
• Failure of prior outpatient antimicrobial therapy. 15

Timing Considerations (Outcome‑Critical)

• Delayed ICU transfer (ward → ICU) is associated with higher mortality; therefore, patients with CURB‑65 ≥ 3 should be evaluated for ICU criteria without delay. 17
• Antibiotic administration should occur within 6 hours of emergency department presentation; each hour of delay worsens outcomes. 17

Guideline Principle – Integration of Scores with Clinical Judgment

• Both the IDSA/ATS severe CAP guidelines and the American Journal of Respiratory and Critical Care Medicine emphasize that scoring systems are adjuncts, not replacements, for clinician judgment; rare conditions (e.g., severe neuromuscular disease, prior splenectomy) may increase poor‑prognosis risk despite low scores. [15][16]